How much will Herceptin really cost?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17124225.
- Also identified by PMC identifier 1661755.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
New guidance from the National Institute for Health and Clinical Excellence recommends Herceptin in early breast cancer, but it provides no additional funding or any suggestion of which services to cut. This leaves medical staff with difficult decisions to make
Medical subject headings
- Antibodies, Monoclonal
- Antineoplastic Agents
- Breast Neoplasms